Systemic lupus erythematosus (SLE) is a multi-faceted autoimmune condition involving the disruption of the immune system and the resultant inflammation and damage to several of the body’s organ systems and tissues. Consequently, SLE is characterized by accelerated morbidity and mortality and a deterioration in the quality of life. Conventional SLE treatments do not promote long-term remission and usually carry significant side effects. Therefore, new therapeutic modalities are required. Regenerative medicine is one of the new frontiers in the treatment of complex autoimmune conditions. For SLE, umbilical cord-derived mesenchymal stem cells (UC-MSCs) are one of the most promising candidates for therapeutic intervention. The best stem cell clinic is the leading resource in many countries for the advanced state-of-the-art medical interventions. In the current climate of therapeutic innovation UC-MSCs offer the first real potential to reset the aberrant immune system of patients with SLE.
Cellular UC-MSCs Mechanisms in SLE
To fully understand the therapeutic potential of the regenerative medicine interventions described for SLE, the complex biological processes that are occurring at the cellular level must be examined. These biological therapies exert their primary effects through very powerful immunomodulatory effects and paracrine signaling. After being delivered by intravenous administration at the best stem cell clinic, UC-MSCs migrate to sites of inflammation through a process of homing, which is mediated by interactions between the cell and the several types of chemokines. When UC-MSCs arrive in an inflamed site, they initiate a variety of cellular changes through the release of various bioactive macromolecules. One of the most important actions involved for SLE is the restoration of immune tolerance through the expansion of regulatory T cells by UC-MSCs, as well as the suppression of T helper 17 cells. In addition, they can suppress the hyperactivity of B cells that leads to the production of autoantibodies and the systemic progression of the disease. This immune recalibration allows the body to begin repairing itself. Constructive immune tolerance allows the body to begin repairing itself at the best stem cell clinic. This can be progressively achieved through the expansion of regulatory T cells and the suppression of B cell activity. This hyperactivity can progress the disease by producing autoantibodies. Systemic manifestations of B cells can be cautiously suppressed to help allow the body to self-repair and minimize the disease state.
Limitations of Conventional SLE Treatment
Current treatments for systemic lupus erythematosus (SLE) rely on severe immunosuppression with corticosteroids and immunosuppressants. To protect organs, clinicians have to control inflammation. This results in large non-specific immunosuppression. This suppression allows the body to protect itself, but causes untold medically-induced suffering for the patient. Long-term exposure to systemic corticosteroids causes persistent and severe effects such as venous thromboembolism, cardiac cachexia, and other manifestations of metabolic syndrome. Many patients experience disease refractory states, in which they become resistant to the intensive and toxic immunosuppressive drug regimen. This acts only as a temporary disease suppression, resulting in frequent cycles of disease flares and toxic medication. Finding safe immunosuppressive drug therapy, or alternatives like UC-MSCs at the best stem cell clinic, has become a number one priority for many SLE patients.
Justification for Cellular Substitution
Advanced regenerative therapies represent a very significant shift in treatment for patients that suffer from SLE and other autoimmune diseases. The use of umbilical cord mesenchymal stem cells (UC-MSCs) demonstrates a clear advantage in treatment of patients with autoimmune diseases at the best stem cell clinic as the cells respond to the individual level of inflammation occurring in each patient. When provided rigorously in line with Good Clinical Practice (GCP) in the best stem cell clinic, UC-MSCs serve as biological intelligent regulators. They sense the degree of the inflammation in the surrounding tissues and release anti-inflammatory cytokines in the exact concentrations necessary to counterbalance the specific threats. Unlike synthetic drugs which force a single unbalanced systemic reaction, these procedures restore a balanced immune homeostasis. Targeted to halt the progression of SLE, these procedures dismantle the sequence of the autoimmune attack and simultaneously support the repair of the compromised endothelial lining of renal systems, as well as the vascular and pulmonary systems.
Figure 1: Conventional SLE treatment compared with Advanced Cellular Substitution
Future Directions in Thailand
The Southeast Asian region is in the process of becoming one of the leading areas for cutting edge regenerative therapeutics. Thailand offers a unique confluence of a highly developed medical and technologically advanced infrastructure, highly talented and specialized research scientists, and progressive and accommodating regulatory frameworks with respect to the research and development of cellular therapeutics. Especially in Bangkok and in the adjacent and highly advanced medical hubs, you can find the best stem cell clinic which provides rigorously tested protocols utilizing umbilical cord mesenchymal stem cells (UC-MSCs) for SLE. Thai research scientists are leading the world in developing the best practices for cellular culture which provide enhanced cellular viability with superior immunomodulatory capabilities. A highly developed network of skilled laboratories to carry out cellular expansion under stringent quality assurance and control practices exists in Thailand. This provides a very solid base for other medical therapeutic approaches. The combination of traditional medical hospitality with state-of-the-art biotechnology provides the world the best medical treatment for the field of stem cell research and extension.